{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:35:49Z","timestamp":1707525349199},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,30]]},"DOI":"10.7759\/cureus.46247","type":"journal-article","created":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T10:50:23Z","timestamp":1696071023000},"source":"Crossref","is-referenced-by-count":0,"title":["Angioedema From Triple Therapy: A Case Report"],"prefix":"10.7759","author":[{"given":"Nicholas","family":"Lepore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taya","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.106081","article-title":"ACE inhibitor-mediated angioedema","volume":"78","author":"Montinaro V","year":"2020","unstructured":"Montinaro V, Cicardi M. ACE inhibitor-mediated angioedema. Int Immunopharmacol. 2020, 78:106081. 10.1016\/j.intimp.2019.106081","journal-title":"Int Immunopharmacol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200629020-00003","article-title":"Current understanding of contrast media reactions and implications for clinical management","volume":"29","author":"Meth MJ","year":"2006","unstructured":"Meth MJ, Maibach HI. Current understanding of contrast media reactions and implications for clinical management. Drug Saf. 2006, 29:133-41. 10.2165\/00002018-200629020-00003","journal-title":"Drug Saf"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s12948-021-00164-7","article-title":"Angioedema associated with dipeptidyl peptidase-IV inhibitors","volume":"19","author":"Cassano N","year":"2021","unstructured":"Cassano N, Nettis E, Di Leo E, Ambrogio F, Vena GA, Foti C. Angioedema associated with dipeptidyl peptidase-IV inhibitors. Clin Mol Allergy. 2021, 19:24. 10.1186\/s12948-021-00164-7","journal-title":"Clin Mol Allergy"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.109.134197","article-title":"Dipeptidyl peptidase-IV inhibitor use associated with increased risk of ACE inhibitor-associated angioedema","volume":"54","author":"Brown NJ","year":"2009","unstructured":"Brown NJ, Byiers S, Carr D, Maldonado M, Warner BA. Dipeptidyl peptidase-IV inhibitor use associated with increased risk of ACE inhibitor-associated angioedema. Hypertension. 2009, 54:516-23. 10.1161\/HYPERTENSIONAHA.109.134197","journal-title":"Hypertension"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-s229","article-title":"DPP-4 inhibitors: impact on glycemic control and cardiovascular risk factors","volume":"34","author":"Dicker D","year":"2011","unstructured":"Dicker D. DPP-4 inhibitors: impact on glycemic control and cardiovascular risk factors. Diabetes Care. 2011, 34:S276-8. 10.2337\/dc11-s229","journal-title":"Diabetes Care"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2020.03.015","article-title":"Angiotensin-converting enzyme and dipeptidyl peptidase-4 inhibitor-induced angioedema: a disproportionality analysis of the WHO pharmacovigilance database","volume":"8","author":"Lepelley M","year":"2020","unstructured":"Lepelley M, Khouri C, Lacroix C, Bouillet L. Angiotensin-converting enzyme and dipeptidyl peptidase-4 inhibitor-induced angioedema: a disproportionality analysis of the WHO pharmacovigilance database. J Allergy Clin Immunol Pract. 2020, 8:2406-8. 10.1016\/j.jaip.2020.03.015","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1161\/hy0202.103054","article-title":"Dipeptidyl peptidase IV activity in patients with ACE-inhibitor-associated angioedema","volume":"39","author":"Lefebvre J","year":"2002","unstructured":"Lefebvre J, Murphey LJ, Hartert TV, Jiao Shan R, Simmons WH, Brown NJ. Dipeptidyl peptidase IV activity in patients with ACE-inhibitor-associated angioedema. Hypertension. 2002, 39:460-4. 10.1161\/hy0202.103054","journal-title":"Hypertension"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2021.10.030","article-title":"Angioedema associated with the use of dihydropyridine calcium channel blockers - a case series","volume":"128","author":"Martinez Manzano JM","year":"2022","unstructured":"Martinez Manzano JM, Lo KB, Jarrett SA, Chiang B, Azmaiparashvili Z. Angioedema associated with the use of dihydropyridine calcium channel blockers - a case series. Ann Allergy Asthma Immunol. 2022, 128:228-9. 10.1016\/j.anai.2021.10.030","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000097770.66965.2A","article-title":"Novel vascular biology of third-generation L-type calcium channel antagonists: ancillary actions of amlodipine","volume":"23","author":"Mason RP","year":"2003","unstructured":"Mason RP, Marche P, Hintze TH. Novel vascular biology of third-generation L-type calcium channel antagonists: ancillary actions of amlodipine. Arterioscler Thromb Vasc Biol. 2003, 23:2155-63. 10.1161\/01.ATV.0000097770.66965.2A","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13090","article-title":"Determinants of angiotensin-converting enzyme inhibitor (ACEI) intolerance and angioedema in the UK Clinical Practice Research Datalink","volume":"82","author":"Mahmoudpour SH","year":"2016","unstructured":"Mahmoudpour SH, Baranova EV, Souverein PC, Asselbergs FW, de Boer A, Maitland-van der Zee AH. Determinants of angiotensin-converting enzyme inhibitor (ACEI) intolerance and angioedema in the UK Clinical Practice Research Datalink. Br J Clin Pharmacol. 2016, 82:1647-59. 10.1111\/bcp.13090","journal-title":"Br J Clin Pharmacol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/180270-angioedema-from-triple-therapy-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:09:29Z","timestamp":1707509369000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/180270-angioedema-from-triple-therapy-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,30]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.46247","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,30]]}}}